1. Department of Neurology, The Chaim Sheba Medical Center, Ramat Gan, Israel
2. Department of Internal Medicine A, The Chaim Sheba Medical Center, Ramat Gan, Israel
3. The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv Israel
Volume 35, Issue 1, March 2024
Sign in to download the Issue in PDF format.
1528709374
Mediterr J Rheumatol 2020; 31(1):75-7
Article Links
Anti-MDA5 Positive Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease and Correlation between Serum Ferritin Level and Treatment Response
Keywords: Anti-MDA5, clinically amyopathic dermatomyositis, interstitial lung disease, MSA, hyperferritinemia
References
- Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanse patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005;52:1571-6.
- Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study. J Am Acad Dermatol 2011 Jul;65(1):25-34.
- Gono T, Miyake k, Kawaguchi Y, Kaneko H, Shinozaki M, Yamanaka H. Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic dermatomyositis. Rheumatology 2012;51:1338-40.
- Nakashima R, Hosono Y, Mimori T. Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease. Lupus 2016 Jul;25(8):925-33.
- Koguchi-Yoshioka H, Okiyama N, Iwamoto K, Matsumura Y, Ogawa T, Inoue S, Watanabe R, Fujimoto M. Intravenous immunoglobulin contributes to the control of antimelanoma differentiation-associated protein 5 antibody-associated dermatomyositis with palmar violaceous macules/papules. Br J Dermatol 2017 Nov;177(5):1442-6.